You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Lavipharm Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for LAVIPHARM, and what generic and branded alternatives to LAVIPHARM drugs are available?

LAVIPHARM has two approved drugs.



Summary for Lavipharm
US Patents:0
Tradenames:7
Ingredients:2
NDAs:2

Drugs and US Patents for Lavipharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lavipharm Labs FENTANYL-100 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 077051-004 Aug 4, 2006 DISCN No No ⤷  Subscribe ⤷  Subscribe
Lavipharm Labs FENTANYL-25 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 077051-001 Aug 4, 2006 DISCN No No ⤷  Subscribe ⤷  Subscribe
Lavipharm CATAPRES-TTS-1 clonidine SYSTEM;TRANSDERMAL 018891-001 Oct 10, 1984 AB RX Yes No ⤷  Subscribe ⤷  Subscribe
Lavipharm Labs FENTANYL-75 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 077051-003 Aug 4, 2006 DISCN No No ⤷  Subscribe ⤷  Subscribe
Lavipharm CATAPRES-TTS-3 clonidine SYSTEM;TRANSDERMAL 018891-003 Oct 10, 1984 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Lavipharm

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lavipharm CATAPRES-TTS-2 clonidine SYSTEM;TRANSDERMAL 018891-002 Oct 10, 1984 4,559,222 ⤷  Subscribe
Lavipharm CATAPRES-TTS-3 clonidine SYSTEM;TRANSDERMAL 018891-003 Oct 10, 1984 4,201,211 ⤷  Subscribe
Lavipharm CATAPRES-TTS-1 clonidine SYSTEM;TRANSDERMAL 018891-001 Oct 10, 1984 4,559,222 ⤷  Subscribe
Lavipharm CATAPRES-TTS-2 clonidine SYSTEM;TRANSDERMAL 018891-002 Oct 10, 1984 4,201,211 ⤷  Subscribe
Lavipharm CATAPRES-TTS-1 clonidine SYSTEM;TRANSDERMAL 018891-001 Oct 10, 1984 3,454,701 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.